Traumatic Brain Injury News and Research

RSS
Traumatic brain injury (TBI), a form of acquired brain injury, occurs when a sudden trauma causes damage to the brain. TBI can result when the head suddenly and violently hits an object, or when an object pierces the skull and enters brain tissue. Symptoms of a TBI can be mild, moderate, or severe, depending on the extent of the damage to the brain. A person with a mild TBI may remain conscious or may experience a loss of consciousness for a few seconds or minutes. Other symptoms of mild TBI include headache, confusion, lightheadedness, dizziness, blurred vision or tired eyes, ringing in the ears, bad taste in the mouth, fatigue or lethargy, a change in sleep patterns, behavioral or mood changes, and trouble with memory, concentration, attention, or thinking. A person with a moderate or severe TBI may show these same symptoms, but may also have a headache that gets worse or does not go away, repeated vomiting or nausea, convulsions or seizures, an inability to awaken from sleep, dilation of one or both pupils of the eyes, slurred speech, weakness or numbness in the extremities, loss of coordination, and increased confusion, restlessness, or agitation.
Graphene may lead to new applications in the diagnosis and treatment of neurological diseases

Graphene may lead to new applications in the diagnosis and treatment of neurological diseases

Education is associated with better recovery from traumatic brain injury, says study

Education is associated with better recovery from traumatic brain injury, says study

Better educated people appear to recover from traumatic brain injury

Better educated people appear to recover from traumatic brain injury

UT Southwestern researchers identify potential new treatment for depression

UT Southwestern researchers identify potential new treatment for depression

Drug used to treat hypertension prevents post-traumatic epilepsy in rodent model

Drug used to treat hypertension prevents post-traumatic epilepsy in rodent model

Neurovive presents new breakthrough on energy regulation at cellular level

Neurovive presents new breakthrough on energy regulation at cellular level

MRI information can speed onset of effective treatments for concussion patients

MRI information can speed onset of effective treatments for concussion patients

Research: Child's relationships may be hidden casualty long after head injury

Research: Child's relationships may be hidden casualty long after head injury

Neurovive stock now trading in the US between $4.00 and $4.21

Neurovive stock now trading in the US between $4.00 and $4.21

Researcher wins 2014 Abraham White Distinguished Science Award for contributions in treatment of neurological diseases

Researcher wins 2014 Abraham White Distinguished Science Award for contributions in treatment of neurological diseases

Leading researchers to convene at 4th Annual Traumatic Brain Injury Conference

Leading researchers to convene at 4th Annual Traumatic Brain Injury Conference

Righttime Medical Care CEO presents lecture on MTBI at Maryland’s annual conference

Righttime Medical Care CEO presents lecture on MTBI at Maryland’s annual conference

NeuroVive presents clinical data of NVP018 for treatment of chronic hepatitis B infections at EASL

NeuroVive presents clinical data of NVP018 for treatment of chronic hepatitis B infections at EASL

Study seeks to adapt multi-family group treatment approach for people with spinal cord injury

Study seeks to adapt multi-family group treatment approach for people with spinal cord injury

NeuroVive Pharmaceutical initiates research collaboration with A1M Pharma

NeuroVive Pharmaceutical initiates research collaboration with A1M Pharma

Homeless people who have suffered TBI are more likely to visit Emergency Department

Homeless people who have suffered TBI are more likely to visit Emergency Department

Neuroscientist explores how the brain restores blood flow to damaged tissue following stroke

Neuroscientist explores how the brain restores blood flow to damaged tissue following stroke

Scientists to study memory and learning in patients with Parkinson disease

Scientists to study memory and learning in patients with Parkinson disease

Elevated body temperature linked to fatigue in relapsing-remitting multiple sclerosis

Elevated body temperature linked to fatigue in relapsing-remitting multiple sclerosis

Neuralstem announces results from Phase I trial using NSI-566 spinal cord stem cells in treatment of ALS

Neuralstem announces results from Phase I trial using NSI-566 spinal cord stem cells in treatment of ALS

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.